Mitral regurgitation is a cardiac ailment characterized by the retrograde flow of blood from the left ventricle back into the left atrium. The mitral valve, responsible for maintaining the unidirectional flow of blood between these cardiac chambers, fails to close properly during each heartbeat, leading to the regurgitation or leakage of blood. This condition imposes an increased workload on the heart as it endeavors to pump an adequate volume of blood to meet the body's physiological demands. Diverse etiological factors contribute to the development of mitral regurgitation, including mitral valve prolapse, rheumatic heart disease, and congenital anomalies. The manifestation of symptoms often includes fatigue, dyspnea (shortness of breath), and the presence of a discernible heart murmur upon auscultation. An early and accurate diagnosis is imperative for instituting timely interventions, as this can help prevent potential complications associated with untreated mitral regurgitation. In the realm of management, various strategies are employed to address this cardiovascular condition. Medical interventions, including pharmacotherapy, play a crucial role in alleviating symptoms and improving heart function. In instances of severe mitral regurgitation, surgical options such as repair or replacement of the mitral valve may be considered to restore normal cardiac function. The choice of intervention is often tailored to the severity of the condition and the individual patient's health status.
Title : Complete heart block and persistent left SVC: A pacing challenge after AV canal repair
Moataz Taha Mahmoud, Madinah Cardiac Center, Saudi Arabia
Title : Chemical detergent anionic surfactant-inducing dry cardiomyopathy (Yasser's cardiomyopathy) with parallel pupils/CXR phenomenon (Yasser's ophthalmic phenomenon), up-down Yasser's alternance, S1Q3 flat T3 pattern - Dramatic response to honey with possible cardiac regeneration - A case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Stabilization of molecular structures in red blood cell membrane by magnetite nanoparticles (ICNB) during storage
Andrey Belousov, Laboratory of Applied Nanotechnology of Belousov and Kharkiv National Medical University, Ukraine